Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PU.1 controls fibroblast polarization and tissue fibrosis.
Wohlfahrt T, Rauber S, Uebe S, Luber M, Soare A, Ekici A, Weber S, Matei AE, Chen CW, Maier C, Karouzakis E, Kiener HP, Pachera E, Dees C, Beyer C, Daniel C, Gelse K, Kremer AE, Naschberger E, Stürzl M, Butter F, Sticherling M, Finotto S, Kreuter A, Kaplan MH, Jüngel A, Gay S, Nutt SL, Boykin DW, Poon GMK, Distler O, Schett G, Distler JHW, Ramming A. Wohlfahrt T, et al. Among authors: pachera e. Nature. 2019 Feb;566(7744):344-349. doi: 10.1038/s41586-019-0896-x. Epub 2019 Jan 30. Nature. 2019. PMID: 30700907 Free PMC article.
OTUD6B-AS1 Might Be a Novel Regulator of Apoptosis in Systemic Sclerosis.
Takata M, Pachera E, Frank-Bertoncelj M, Kozlova A, Jüngel A, Whitfield ML, Assassi S, Calcagni M, de Vries-Bouwstra J, Huizinga TW, Kurreeman F, Kania G, Distler O. Takata M, et al. Among authors: pachera e. Front Immunol. 2019 May 17;10:1100. doi: 10.3389/fimmu.2019.01100. eCollection 2019. Front Immunol. 2019. PMID: 31156645 Free PMC article.
Long noncoding RNA H19X is a key mediator of TGF-β-driven fibrosis.
Pachera E, Assassi S, Salazar GA, Stellato M, Renoux F, Wunderlin A, Blyszczuk P, Lafyatis R, Kurreeman F, de Vries-Bouwstra J, Messemaker T, Feghali-Bostwick CA, Rogler G, van Haaften WT, Dijkstra G, Oakley F, Calcagni M, Schniering J, Maurer B, Distler JH, Kania G, Frank-Bertoncelj M, Distler O. Pachera E, et al. J Clin Invest. 2020 Sep 1;130(9):4888-4905. doi: 10.1172/JCI135439. J Clin Invest. 2020. PMID: 32603313 Free PMC article.
Vaccination-based immunotherapy to target profibrotic cells in liver and lung.
Sobecki M, Chen J, Krzywinska E, Nagarajan S, Fan Z, Nelius E, Monné Rodriguez JM, Seehusen F, Hussein A, Moschini G, Hajam EY, Kiran R, Gotthardt D, Debbache J, Badoual C, Sato T, Isagawa T, Takeda N, Tanchot C, Tartour E, Weber A, Werner S, Loffing J, Sommer L, Sexl V, Münz C, Feghali-Bostwick C, Pachera E, Distler O, Snedeker J, Jamora C, Stockmann C. Sobecki M, et al. Among authors: pachera e. Cell Stem Cell. 2022 Oct 6;29(10):1459-1474.e9. doi: 10.1016/j.stem.2022.08.012. Epub 2022 Sep 15. Cell Stem Cell. 2022. PMID: 36113462 Free article.
The AP-1 transcription factor Fosl-2 drives cardiac fibrosis and arrhythmias under immunofibrotic conditions.
Stellato M, Dewenter M, Rudnik M, Hukara A, Özsoy Ç, Renoux F, Pachera E, Gantenbein F, Seebeck P, Uhtjaerv S, Osto E, Razansky D, Klingel K, Henes J, Distler O, Błyszczuk P, Kania G. Stellato M, et al. Among authors: pachera e. Commun Biol. 2023 Feb 9;6(1):161. doi: 10.1038/s42003-023-04534-6. Commun Biol. 2023. PMID: 36759717 Free PMC article.
Author Correction: The AP-1 transcription factor Fosl-2 drives cardiac fibrosis and arrhythmias under immunofibrotic conditions.
Stellato M, Dewenter M, Rudnik M, Hukara A, Özsoy Ç, Renoux F, Pachera E, Gantenbein F, Seebeck P, Uhtjaerv S, Osto E, Razansky D, Klingel K, Henes J, Distler O, Błyszczuk P, Kania G. Stellato M, et al. Among authors: pachera e. Commun Biol. 2023 Feb 23;6(1):213. doi: 10.1038/s42003-023-04600-z. Commun Biol. 2023. PMID: 36823451 Free PMC article. No abstract available.